•
Sep 30, 2012

Cocrystal Pharma Q3 2012 Earnings Report

Total Revenue
$4.89M
Previous year: $3.93M
+24.5%
EPS
$0.12
Previous year: -$0.04
-400.0%
Gross Profit
$2.02M
Previous year: $1.79M
+13.3%
Cash and Equivalents
$82.6K
Previous year: $782K
-89.4%
Total Assets
$8.26M
Previous year: $10.7M
-22.8%

Cocrystal Pharma

Cocrystal Pharma